Johnson & Johnson JNJ

$280.41 -0.37 (-0.13%)

Valuation

Market cap
675,924,480,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
P/E (trailing)
26.49
P/E (forward)
25.38
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
5,437,200
Avg volume
7,213,832
Day's range
$276.59 – $281.16
Shares out
2,407,310,000
Stochastic %K
84%
Beta
0.22
Analysts
Moderate Buy
Price target
$281.64

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

Stocktwits52wHighs Nov 12, 4:46 PM
$JNJ printed a new 52-week high today
0 replies
UnMaker Nov 12, 4:22 PM
$BB Do I need to tag all partners? $JNJ $XPEV $MSFT $LCID
0 replies
HydrogenH2 Nov 12, 3:56 PM
$JNJ Johnson & Johnson $283.70 + $60.70 +(27.22%) Past 6 Months Have a great day !! I'm out for now !!
0 replies
SellasgpsCurativeBAT11 Nov 12, 3:35 PM
$SLS $JNJ $PFE $BMY $ABBV Independent BOD Bach has MNPI and involved in the BO, can’t sell those shares on open market. Insiders buys stopped after JP Morgan 1x1 conference November 2025. There are multiple big pharmaceuticals on the table pending Primary Top line Regal Phase 3 data before Consummating a deal. ✌️🙏❤️‍🩹
0 replies
BurchJJ Nov 12, 2:33 PM
$CNSY there is a 100% chance this closes over $1 today 100% I have ZERO DOUBT The run is just stating. Enjoy it folks $NVDA $JNJ $XBI
1 replies
Mountainmannn Nov 12, 12:38 PM
$MRNA our Legal stance is... you can steal intellectual property for government contracts and continue to use them for anything without compensation... Big bank equity bags, easy remedies, buyout coming for $ABUS. I'd love to see $JNJ rug pull everyone! 😂
1 replies
BigAllergies Nov 12, 2:07 AM
Rep. Ro Khanna's sale of $JNJ on Oct 7 was worth $50K to $100K, per the House filing. Johnson & Johnson is up 8.6% since the sale. getbreakaway.com/JNJ
0 replies
PhantomZ Nov 12, 1:16 AM
$IBRX $CGON $MRK $JNJ another promising One and Done NMIBC CIS treatment, which may one day be combined with Anktiva as it is now also being trialed in Combo with Adstiladrin.IMO https://globalonemedia.zoom.us/webinar/register/WN_bv5UD0EURFaG2rR7uWwOEw#/registration?os=ipad
0 replies